<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Proton therapy range uncertainty reduction using vendor-agnostic tissue characterization on a virtual photon-counting CT head scan - Health AI Hub</title>
    <meta name="description" content="This paper introduces virtual imaging simulators as a novel approach to validate proton therapy range uncertainty in complex patient geometries using a computat">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Proton therapy range uncertainty reduction using vendor-agnostic tissue characterization on a virtual photon-counting CT head scan</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2512.22026v1" target="_blank">2512.22026v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-12-26
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> S. Vrba≈°ki, G. Staniƒá, S. Mollineli, M. Bhattarai, E. Abadi, M. Ciocca, E. Samei
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> physics.med-ph
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.95 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2512.22026v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2512.22026v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper introduces virtual imaging simulators as a novel approach to validate proton therapy range uncertainty in complex patient geometries using a computational head model and photon-counting CT. It demonstrates that a prototype software, TissueXplorer, leveraging spectral CT information, significantly improves stopping power ratio (SPR) estimation and subsequent dose distribution accuracy compared to conventional methods, thereby reducing range uncertainty.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>Accurate stopping power ratio prediction is crucial for precise proton therapy, as it directly impacts the proton range and thus the dose delivery to the tumor while sparing surrounding healthy tissues, improving treatment efficacy and minimizing side effects.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The paper describes a 'prototype software, TissueXplorer' that utilizes spectral information for more accurate prediction of stopping power ratios. While this is an advanced computational application for healthcare, the abstract does not explicitly state that it employs Artificial Intelligence or Machine Learning techniques. It is a software solution for medical image analysis and treatment planning, which could potentially incorporate AI, but is not explicitly defined as such in the provided text.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Virtual imaging simulators are proposed as an alternative method for experimental validation of proton beam range uncertainty in complex patient geometries.</li>
                    
                    <li>A computational human head model was used with simulated photon-counting CT (PCCT) projections, reconstructed with open-source tools.</li>
                    
                    <li>Stopping Power Ratio (SPR) calculations were compared between a conventional stoichiometric calibration method and a prototype spectral CT-based software, TissueXplorer.</li>
                    
                    <li>Proton therapy dose of 2 Gy was simulated for two cases: nasal and brain tumors, using a single lateral beam angle.</li>
                    
                    <li>A ground truth treatment plan was generated directly on the computational head model using clinical treatment planning software (RayStation).</li>
                    
                    <li>TissueXplorer achieved a mean percentage difference of 0.28% in SPR estimation across all head tissues within the scanned volume.</li>
                    
                    <li>SPR values derived from TissueXplorer resulted in smaller differences in dose distribution from the ground truth plan compared to the conventional stoichiometric calibration method.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The study utilized a virtual imaging simulation framework. A validated CT simulator (DukeSim) generated photon-counting CT projections of a computational head model, which were then reconstructed. Proton therapy plans (2 Gy for nasal/brain tumors) were created. A 'ground truth' plan was established directly on the computational model. SPR values were estimated from the reconstructed CT images using both a conventional stoichiometric approach and the prototype TissueXplorer software. The ground truth plan was then recalculated using SPRs from both methods, and the resulting dose distributions were quantitatively compared against the ground truth to assess accuracy.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>TissueXplorer demonstrated superior accuracy in SPR estimation, achieving a mean percentage difference of only 0.28% across all head tissues. Crucially, the SPR values obtained using TissueXplorer led to dose distributions that exhibited smaller differences from the ground truth plan compared to those derived from the conventional stoichiometric calibration method, indicating a more precise prediction of proton range and dose deposition.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This research suggests that integrating spectral CT data, through advanced software like TissueXplorer, could significantly enhance the accuracy of proton therapy planning by reducing beam range uncertainty. This has the potential to enable more conformal dose delivery to tumors, improve tumor control probability, and minimize toxicity to critical organs at risk, ultimately leading to better clinical outcomes for patients undergoing proton therapy for brain or head and neck cancers.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The study is a 'simulation study' utilizing 'virtual imaging,' implying that its findings have not been validated *in vivo* or with real patient data. TissueXplorer is described as a 'prototype software,' suggesting it is not yet a fully mature or clinically deployed solution. Generalizability across all patient anatomies, tumor types, and different proton therapy systems may require further investigation.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The study highlights that software solutions leveraging spectral information, like TissueXplorer, hold promise for more accurate SPR prediction, implicitly suggesting further development, refinement, and validation of such technologies. Virtual imaging itself is proposed as a valuable alternative for ongoing validation of SPR prediction and its impact on clinical outcomes, indicating its continued utility for future research and development in this field.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Radiation Oncology</span>
                    
                    <span class="tag">Medical Physics</span>
                    
                    <span class="tag">Diagnostic Imaging</span>
                    
                    <span class="tag">Neuro-oncology</span>
                    
                    <span class="tag">Head and Neck Oncology</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">proton therapy</span>
                    
                    <span class="tag tag-keyword">range uncertainty</span>
                    
                    <span class="tag tag-keyword">photon-counting CT</span>
                    
                    <span class="tag tag-keyword">stopping power ratio</span>
                    
                    <span class="tag tag-keyword">TissueXplorer</span>
                    
                    <span class="tag tag-keyword">virtual imaging</span>
                    
                    <span class="tag tag-keyword">dose distribution</span>
                    
                    <span class="tag tag-keyword">radiation oncology</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">In this work, we proposed virtual imaging simulators as an alternative approach to experimental validation of beam range uncertainty in complex patient geometry using a computational model of a human head and a photon-counting CT scanner. We validate the accuracy of stopping power ratio (SPR) calculations using a conventional stoichiometric calibration approach and a prototype software, TissueXplorer. A validated CT simulator (DukeSim) was used to generate photon-counting CT projections of a computational head model, which were reconstructed with an open-source toolbox (ASTRA). The dose of 2 Gy was delivered through protons in a single fraction to target two different cases of nasal and brain tumors with a single lateral beam angle. Ground truth treatment plan was made directly on the computational head model using clinical treatment planning software (RayStation). This plan was then recalculated on the corresponding CT images for which SPR values were estimated using both the conventional method and the prototype software TissueXplorer. The mean percentage difference in estimating the stopping power ratio with TissueXplorer in all head tissues inside the scanned volume was 0.28%. Stopping power ratios obtained with this method showed smaller dose distribution differences from the ground truth plan than the conventional stoichiometric calibration method on the computational head model. Virtual imaging offers an alternative approach to validation of the SPR prediction from CT imaging, as well as its effect on the dose distribution and thus downstream clinical outcomes. According to this simulation study, software solutions that utilize spectral information, such as TissueXplorer, hold promise for more accurate prediction of the stopping power ratio than the conventional stoichiometric approach.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>16 pages, 5 figures</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>